High blood pressure that refuses to improve with treatment may sometimes have a hidden cause. Hyperaldosteronism is one condition that can quietly affect hormone balance and cardiovascular health without clear warning signs. What if newer diagnostic tools are changing how this disorder is detected and treated? An Endocrinologist Specializing in Adrenal Disorders may play a key role in uncovering answers many patients never expected.
TL;DR
Recent advances in diagnosing hyperaldosteronism focus on earlier detection in patients with resistant hypertension and low potassium using the aldosterone–renin ratio (ARR) as the primary screening test. Blood and urine tests, imaging, and confirmatory procedures help identify the underlying cause, such as adrenal tumors or bilateral gland enlargement. Once diagnosed, treatment is tailored through surgery or medication, with continuous monitoring of blood pressure, potassium levels, and kidney function to reduce cardiovascular risks and improve long-term outcomes.
Details from Endocrinologist Specializing in Adrenal Disorders
How Has Hyperaldosteronism Diagnosis Improved Recently?
The diagnosis of primary hyperaldosteronism has improved through more precise algorithms that prioritize early screening in patients with difficult-to-control hypertension. Screening is now recommended for individuals with low potassium levels as well as those with resistant hypertension, difficult-to-manage hypertension, or hypertension appearing before age 50.
Another major improvement is the standardized use of the aldosterone–renin ratio (ARR) as the initial screening test. To obtain reliable results, certain medications that interfere with hormone measurement—such as spironolactone, beta-blockers, ACE inhibitors, or angiotensin receptor blockers—are often temporarily discontinued.
Confirmatory tests, including saline infusion and the captopril test, together with imaging techniques such as computed tomography and adrenal vein sampling, allow clinicians to identify the source of excess aldosterone more accurately. These tools help distinguish adrenal adenomas and adrenal hyperplasia, supporting earlier and more precise diagnosis.
Detecting Hormone Imbalances Early
Early detection focuses on identifying patients with resistant or difficult-to-control hypertension, especially when it is associated with low potassium levels (hypokalemia), even when the decrease is mild. Initial screening commonly involves measuring the aldosterone-to-renin ratio in plasma, which is typically elevated in individuals with this hormonal disorder.
Key warning signs and early diagnostic methods include:
- Resistant hypertension: Blood pressure that does not respond adequately to standard treatments.
- Hypokalemia: Low potassium levels in the blood, although this may not appear in every patient.
- Neuromuscular symptoms: Muscle weakness, tingling, cramps, and fatigue related to electrolyte imbalance.
- Kidney-related symptoms: Increased urination (polyuria) and frequent nighttime urination (nocturia).
- Initial screening test (aldosterone–renin ratio): A test used to identify patients with a higher probability of hyperaldosteronism.
- Confirmatory tests: Saline loading tests and captopril tests evaluate whether aldosterone levels decrease appropriately.
- Imaging studies: Computed tomography (CT) or magnetic resonance imaging (MRI) may detect adrenal adenomas or enlarged adrenal glands.
- Adrenal vein catheterization: A procedure used to determine whether excess hormone production originates in one adrenal gland or both.
Identifying these hormonal abnormalities early helps confirm the diagnosis and guide treatment decisions. Early detection can reduce the risk of complications related to excess aldosterone, including cardiovascular and kidney damage linked to persistent hypertension.
Using Blood and Urine Tests Effectively
Effective diagnosis relies mainly on laboratory tests that detect hormonal imbalances associated with excessive aldosterone production. The most widely used initial test measures the aldosterone–renin ratio in the blood, identifying elevated aldosterone levels alongside suppressed renin. These tests are usually performed after discontinuing medications that could interfere with hormone measurement.
Accurate blood and urine testing requires careful preparation and patient selection.
- Who should be tested? Patients with resistant hypertension, hypertension combined with hypokalemia, hypertension appearing before age 50, or the presence of adrenal incidentalomas.
- Pre-test preparation: Patients should maintain adequate potassium levels and follow a normal-sodium diet. Medications such as spironolactone are typically discontinued 4–6 weeks before testing, while ACE inhibitors or angiotensin receptor blockers are stopped at least two weeks in advance to prevent inaccurate results.
- Blood testing (ARR): Measuring the aldosterone–renin ratio serves as the primary screening tool. An elevated ratio may indicate excess aldosterone and possible primary hyperaldosteronism.
- 24-hour urine analysis: This test measures aldosterone and sodium excretion over a full day and helps confirm excessive hormone production.
Appropriate use of blood and urine tests allows earlier detection of this hormonal condition. Identifying it sooner helps reduce complications linked to excess aldosterone, including cardiovascular damage and other effects associated with persistent hypertension.
Identifying Underlying Causes Clearly
An accurate diagnosis requires identifying the underlying cause of the disorder. This condition is generally classified as primary hyperaldosteronism, when the issue originates in the adrenal glands, or secondary hyperaldosteronism, when it occurs as a response to other diseases that affect circulation or kidney function.
Hyperaldosteronism can be divided into several categories depending on the origin of excess aldosterone.
Causes of Primary Hyperaldosteronism
These causes are linked to structural or functional problems in the adrenal glands.
- Adrenal adenoma (aldosteronoma): A benign tumor that produces excess aldosterone and accounts for about 30–40% of cases.
- Idiopathic adrenal hyperplasia: Enlargement of both adrenal glands and the most common cause, responsible for about 60–65% of cases.
- Adrenal carcinoma: A rare malignant tumor.
- Familial hyperaldosteronism: A rare hereditary condition associated with genetic predisposition.
Causes of Secondary Hyperaldosteronism
Secondary hyperaldosteronism develops when other diseases activate hormonal mechanisms that increase aldosterone production.
- Renal artery stenosis: Narrowing of the arteries supplying the kidneys, which triggers signals suggesting low blood pressure.
- Congestive heart failure: Reduced cardiac pumping efficiency activates the renin-angiotensin-aldosterone system.
- Liver cirrhosis: Circulatory changes that promote fluid retention.
- Nephrotic syndrome: Significant loss of protein through urine.
Diagnosis is confirmed through blood tests that measure aldosterone and renin levels, as well as sodium and potassium levels. Imaging tests such as computed tomography can also detect abnormalities in the adrenal glands and help determine the source of excess hormone production.
Tailoring Treatment Plans for Patients
Personalized treatment plays a central role in controlling blood pressure, correcting hypokalemia, and reducing cardiovascular and kidney risks. Adapting therapy according to the underlying cause helps determine whether surgery or medication is the most appropriate approach, supporting better long-term outcomes and quality of life.
Why Personalized Treatment Matters
An individualized approach allows clinicians to design treatment plans based on the cause of excess aldosterone and the patient’s clinical characteristics.
| Aspect | How It Influences Treatment |
| Cause identification | Determines whether treatment involves surgery or medication |
| Risk control | Helps reduce cardiovascular and kidney complications associated with hypertension |
| Potassium management | Supports correction of hypokalemia through treatment adjustments |
| Treatment adherence | Encourages long-term compliance and may reduce side effects |
Treatment Approaches Based on the Underlying Cause
Treatment selection depends mainly on whether hyperaldosteronism affects one adrenal gland or both.
- Adrenalectomy (surgery): Used when a unilateral adrenal tumor is present, such as in Conn’s syndrome.
- Medication therapy: Bilateral adrenal hyperplasia is usually treated with mineralocorticoid receptor antagonists such as spironolactone or eplerenone.
- Medication adjustment: Dosages can be modified to stabilize potassium levels and improve blood pressure control.
When treatment aligns with the underlying cause, blood pressure control improves and complications related to the condition decrease. This approach also supports stable potassium levels, encourages treatment adherence, and reduces long-term cardiovascular and kidney risks.
Monitoring Progress and Adjusting Care
Managing hyperaldosteronism requires continuous follow-up to evaluate patient progress and confirm that treatment remains effective. Monitoring includes regular checks of blood pressure, potassium levels, and kidney function, since excess aldosterone can alter these parameters and contribute to resistant hypertension.
Laboratory tests that measure aldosterone and renin levels are also used during follow-up to assess treatment response. Because hormone levels may vary, repeated measurements are sometimes necessary to obtain accurate results.
Treatment adjustments may include the use of aldosterone antagonists such as spironolactone or eplerenone, changes in antihypertensive medications, and lifestyle modifications such as reducing salt intake. In some cases of unilateral primary hyperaldosteronism, surgery may be considered to improve blood pressure and potassium control.
Key Takeaways
- Improved diagnosis methods: New screening strategies and the aldosterone–renin ratio (ARR) help detect hyperaldosteronism earlier and identify its cause more accurately.
- Early detection in high-risk patients: People with resistant hypertension, low potassium, or early-onset hypertension are key candidates for early screening.
- Role of blood and urine tests: Blood ARR testing and 24-hour urine analysis confirm excess aldosterone and support accurate diagnosis.
- Identifying the underlying cause: Determining whether hyperaldosteronism is primary or secondary guides the appropriate treatment approach.
- Personalized treatment and monitoring: Treatment may include surgery or medication, with continuous monitoring to control blood pressure and prevent complications.
Sources
- Araujo-Castro, M. (2020). Treatment of primary hyperaldosteronism. Medicina Clínica (English Edition), 155(7), 302-308.
https://www.sciencedirect.com/science/article/abs/pii/S2387020620304046
- Lattanzio, M. R., & Weir, M. R. (2020). Hyperaldosteronism: how current concepts are transforming the diagnostic and therapeutic paradigm. Kidney360, 1(10), 1148-1156.
FAQs
What happens when someone has hyperaldosteronism?
When someone has hyperaldosteronism, the adrenal glands produce too much aldosterone, which can cause persistent high blood pressure and low potassium levels. Over time, this imbalance may damage organs such as the kidneys, heart, eyes, and brain. Symptoms may include fatigue, muscle cramps, and frequent urination.
What is the difference between Conn’s syndrome and hyperaldosteronism?
Conn’s syndrome is a form of primary hyperaldosteronism, where the adrenal glands produce excess aldosterone due to a problem within the gland itself, often a benign tumor or adrenal hyperplasia. Hyperaldosteronism is the broader condition describing excess aldosterone production. Conn’s syndrome is commonly used to refer to the adrenal-related form of the disorder.
What is the main cause of primary hyperaldosteronism?
The most common causes of primary hyperaldosteronism are bilateral adrenal hyperplasia and an aldosterone-producing adrenal adenoma. Both conditions lead to excessive production of aldosterone in the adrenal glands. This hormonal imbalance contributes to hypertension and low potassium levels.
What is the best diet for hyperaldosteronism?
A diet low in sodium and rich in potassium may help support blood pressure balance in people with hyperaldosteronism. Eating whole, minimally processed foods can also contribute to maintaining healthy blood pressure and body weight. This type of anti-inflammatory eating pattern may complement medical treatment and support overall cardiovascular health.